Buscar resultados de ensayos clínicos
Adrenocortical Carcinoma - 9 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma Condición: Adrenocortical Carcinoma Fecha: 2006-05-08 Intervenciones: Drug: cisplatin, taxotere cisplatin 75 mg/m2 Taxotere 75 mg/m2 |
| Terminated |
Nombre del estudio: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery Condición: Adrenocortical Carcinoma Fecha: 1999-11-01 Intervenciones:
|
| Active, not recruiting |
Nombre del estudio: Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma Condición:
Fecha: 2007-04-04 |
| Completed |
Nombre del estudio: A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection Condición: Adrenal Cortical Carcinoma Fecha: 1999-11-03 Intervenciones: Drug: doxorubicin, vincristine, and etoposide with mitotane |
| Completed |
Nombre del estudio: A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent Condición: Neoplasms Fecha: 2005-12-12 Intervenciones: Drug: ADH -1 (Exherin™) |
| Completed |
Nombre del estudio: Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) Condición: Solid Tumors Fecha: 2013-01-14 Intervenciones: Drug: Avelumab Avelumab will be administered in study location using a protocol-defined dose escalation |
| Completed |
Nombre del estudio: Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma Condición: Adrenocortical Carcinoma Fecha: 2025-07-31 Intervenciones: All participants will first undergo ablative RT |
| Completed |
Nombre del estudio: Phase 1 Study of 68Ga-R8760 Condición: Adrenocortical Carcinoma Fecha: 2025-07-31 Intervenciones: PET/CT imaging at predefined timepoints |
| Completed |
Nombre del estudio: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma Condición: Adrenocortical Carcinoma Fecha: 2025-07-31 Intervenciones: Given by PO |